Pallas Capital Advisors LLC Novartis Ag Transaction History

Pallas Capital Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 22, 2024	BUY	$92.27 - $101.54 $516,342 - $568,217	5,596 New	5,596 $565,000
Q1 2023 May 02, 2023	SELL	$80.03 - $92.81 $79,389 - $92,067	-992 Reduced 30.61%	2,249 $206,000
Q4 2022 Jan 24, 2023	BUY	$75.55 - $92.52 $13,296 - $16,283	176 Added 5.74%	3,241 $0
Q3 2022 Nov 07, 2022	BUY	$74.61 - $87.26 $746 - $872	10 Added 0.33%	3,065 $246,000
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $17,633 - $20,531	-219 Reduced 6.69%	3,055 $262,000
Q1 2022 Apr 20, 2022	SELL	$80.11 - $90.62 $114,076 - $129,042	-1,424 Reduced 30.31%	3,274 $303,000
Q4 2021 Feb 01, 2022	SELL	$79.7 - $88.13 $161,791 - $178,903	-2,030 Reduced 30.17%	4,698 $409,000
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $143,851 - $167,351	1,759 Added 35.4%	6,728 $562,000
Q2 2021 Aug 11, 2021	BUY	$85.24 - $94.15 $55,406 - $61,197	650 Added 15.05%	4,969 $455,000
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $360,636 - $425,291	4,319 New	4,319 $380,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pallas Capital Advisors LLC with notifications on news.